Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis
By P. Amarenco, J. Labreuche, Philippa C. Lavallée, P. Touboul. Stroke, 2004
762 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/f0d20c67c1ea37b48d68ae4bd1d7124e06926b84
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Pulmonary and Respiratory Medicine
In Surgery
Citations in the corpus
- ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). (2011, background): “Based on the available evidence, apo B appears to be a risk factor at least as good as LDL-C and a better index of the adequacy of LDL-lowering therapy than LDL-C.46 Also, there now appears to be less laboratory error in the determination of apo B than of LDL-C, particularly in patients with HTG.”
- Stroke Risk Factors, Genetics, and Prevention (2017, result): “Although these studies show potentially inconsistent and opposite findings between dyslipidemia and risk of ischemic and hemorrhagic stroke, in the general patient population, the use of statins seems to reduce the risk of total and ischemic stroke with no definite increase in the risk of hemorrhagi”
- Guidelines for the Primary Prevention of Stroke (2011, neutral): “Meta-analyses of statin trials found that statin therapy slows the progression of carotid IMT and that the magnitude of LDL cholesterol reduction correlates inversely with the progression of carotid IMT.(153,163) Moreover, beneficial effects on carotid IMT are greater with higher-intensity statin th”
- 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. (2016, background): “90 000 patients, Amarenco et al.(410) reported that statin therapy leads to a 21% reduction in the incidence of all strokes in different populations and that this effect is mainly driven by the extent of LDL-C reduction.”